RE: RNS18 Sep 2018 15:36
Same young lady did this in May 2017 :TURKU - FINLAND, 22 May 2017 - Faron Pharmaceuticals Ltd ("Faron") (LON: FARN), the clinical stage biopharmaceutical company, announces that on 19 May 2017 it was notified that a person closely associated with Dr Matti Karvonen, Medical Director of Faron has acquired 1000 ordinary shares in Faron at a price of 760 pence and 1700 ordinary shares in Faron at a price 780 pence per ordinary share.